I would be very apprehensive with oil stocks after the Iran deal. If they flood global market with cheap oil....nobody wins
Thanks for all of the responses. I am going to ride this one out and see where it goes. Luckily my other stocks are doing well.
second rate product? McDonalds sells a second rate product....i wonder when it will catch up with them....your logic is flawed.
I sold out of my position. I still like the company and pocketed more than a few bucks but I think there are better investment options right now.
I bought this stock awhile ago. One of those buy and forget about it companies.....that was a mistake. The future of this company once had looked bright, but I don't see it anymore.
Anyone have some no spin advice?
Long holders will be fine. Looking at volume so far I would say you have a lot of breath holding with peoples fingers on buttons.
Doubtful it will go lower than $6. Institutional support now that the company didn't have previously. This is a case of 1 step back to move 3 steps forward in the long run.
You will still make the same amount of money regardless of the split. ONCS has too many positive trials and a ton of positive clinical data to not make you money in the long run.
Too funny, your going to end up getting short squeezed. But I hope many people attempt that strategy. It just means that you will be buying to cover with a smaller inventory available, which will drive the price higher...
Everyone knows the collaboration with Merck and ONCS, and now Adil Daud the chair of ONCS' melanoma advisory committee will be presenting Keytruda data at ASCO. This is very good news for those long ONCS. We will be on biggest stage with one of the biggest players in industry. And the more I dig through the released ASCO abstracts the bigger the impact I see ONCS making through their collaborative efforts.
A few others caught my attention as well but these are long reads.
many of the naysayers will be gone from this board once split is completed. I hope you are right about the good news to follow soon after.